EyeD Pharma
PrivateLast Round
VC Round
Dec 22, 2021
Total Funding Raised
$22.37M
Company Overview
EyeD Pharma operates in Healthcare & Life Sciences and is based in Liège. Its latest recorded funding round was a VC Round in December 2021.
EyeD Pharma is a biotechnology company that develops innovative therapeutic solutions for ophthalmic diseases using sustained-release micro-implants and complex drug delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EyeD Pharma Comparables
Compare EyeD Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PolyActiva | 86% | |
| Ripple Therapeutics | 84% | |
| ReBio Technologies Oy | 81% |
For institutional investors. Book with your work email.
EyeD Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 22, 2021 | ||||
| VC Round | May 20, 2019 | ||||
| Debt | May 20, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EyeD Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | VC Round |
| Noshaq | VC Round |
| Fund+ | VC Round |
| Wallonie Entreprendre | VC Round |
| Nomainvest | VC Round |
| Qbic II | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 442% MoM, reaching 8.4K.
- May 11, 2026
Monthly visitors grew 233% MoM, from 466 to 1.6K.
For institutional investors. Book with your work email.
EyeD Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EyeD Pharma's valuation, stock price, and market status.
Is EyeD Pharma a public or private company?
EyeD Pharma is a private company.
What is the current stock price of EyeD Pharma?
EyeD Pharma is a private company, so its shares have no public market price. Caplight tracks EyeD Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EyeD Pharma worth (valuation)?
Valuation information for EyeD Pharma is not publicly available.
Can I buy EyeD Pharma stock?
EyeD Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EyeD Pharma's last funding round?
EyeD Pharma's most recent funding round was VC Round on December 22, 2021.
Who are the main investors in EyeD Pharma?
Key investors in EyeD Pharma include Fund+.
Will EyeD Pharma IPO soon?
No public IPO plans have been announced for EyeD Pharma.
How can I track EyeD Pharma secondary market activity?
Caplight tracks bids, offers, and trades in EyeD Pharma's shares on secondary markets.